Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
about
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological TargetsDiametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologyFuture clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniaBrain/MINDS: brain-mapping project in JapanMismatch negativity in common marmosets: Whole-cortical recordings with multi-channel electrocorticograms.Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis.Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity.Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.Mismatch negativity (MMN) as an index of cognitive dysfunctionMismatch negativity latency as a biomarker of amnestic mild cognitive impairment in chinese rural elders.Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnessesReduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode PsychosisEquivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?Neurophysiology for Detection of High Risk for PsychosisContributions of experimental psychiatry to research on the psychosis prodrome.Impairment in predictive processes during auditory mismatch negativity in ScZ: Evidence from event-related fields.Bending the curve on psychosis outcomes.Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins.Disruption of information processing in schizophrenia: The time perspective.Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.Effects of an NMDA antagonist on the auditory mismatch negativity response to transcranial direct current stimulation.Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.Intact neural activity during a Go/No-go task is associated with high global functioning in schizophrenia.Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review.Magnetoencephalographic recording of auditory mismatch negativity in response to duration and frequency deviants in a single session in patients with schizophrenia.Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?
P2860
Q26767499-9C53158F-75F3-488E-ABAE-14EB34AE9CFCQ26782139-2986AA90-4308-4CB0-B749-9CEDF39DD460Q27014120-363DD4E0-4CA9-4CF2-BC5C-78574A7BB4EDQ28080623-D6F417C4-A712-413E-A63F-A830DB1C919EQ28606533-3A18EA69-CA49-4A7F-80A6-773EADDE5CABQ30250337-93EF5AEE-2713-474A-8E73-76F366A00E96Q30362549-3C64A10B-CB66-417E-B77D-5A212E4394A9Q30384905-E7C200CE-C254-4306-8717-381562951DDFQ30387378-5A6AA736-ACFF-4AE1-A8DE-510C794A21CEQ30407708-B36D6877-A9F1-42CB-83E1-18ACDECCC6C8Q30415954-7B40DE51-9499-4623-AF9E-ED6A42E8F16AQ30421612-1193FF41-BCD2-4A27-B107-49B689ADBA3FQ33720060-DFEDD98F-13B5-40DE-8599-DB520304C358Q35108892-1ADD6D27-CEF6-40C8-9212-2CA7914162B9Q35542864-020C3922-2729-4B54-89CB-9033288E7A16Q37192509-05CC8CB5-12FF-41DD-B049-7DB47F55EF3FQ38175023-D3874814-F7F2-40D0-9283-552BBFFE6829Q38693536-62300DAD-D6C7-4370-8338-2A535951DB71Q41517439-CD2D4264-E8D0-4954-ADE0-52E8A060A820Q41653821-B6FF82B8-7CCD-480D-ABF2-DE141D599F01Q43376599-379637C7-6A2C-4032-9168-BC697A7DCD89Q46116077-5EAF5AEE-203F-4608-994D-9927729F02B0Q47596285-2F10E30E-4725-4510-A8D7-878A6D80CDAEQ47939458-F64D0EF6-C557-42F2-BF56-77A4BE7C87F9Q48559497-740ED1AA-EC0D-4268-9DC1-E4CC86AACD75Q50527134-9E047C0F-D562-42A2-9425-95A705365978Q51735519-AA37CA68-7616-4280-961F-E74EBC72C6A3Q54715729-D7A499E9-A6A7-4839-A5B6-DFEA36B5906EQ58598687-A109A5FC-F3D2-43A0-AE77-7C810F94A7BA
P2860
Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@en
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@nl
type
label
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@en
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@nl
prefLabel
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@en
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@nl
P2093
P2860
P356
P1476
Mismatch negativity as a "tran ...... ntion for psychosis: a review.
@en
P2093
Kenji Kirihara
Mariko Tada
Seiichiro Jinde
Tatsuya Nagai
Tsuyoshi Araki
P2860
P356
10.3389/FPSYT.2013.00115
P50
P577
2013-09-23T00:00:00Z